Skip to main content
  • COVID-19
    • COVID-19 vaccines and cancer
      • FAQs
      • FAQs in-language
      • SerOzNET Study
    • COVID-19 information for people affected by cancer
      • Managing your cancer care in the context of COVID-19
      • Looking after your mental wellbeing
      • Canada
      • Ireland
      • UK
      • USA
    • COVID-19 information for children and young people with cancer
    • Cancer Won’t Wait
    • Cancer and COVID-19 - what it means for our Mob
      • COVID-19 vaccines: Information for Aboriginal and Torres Strait Islander people affected by cancer
      • Act early for our Mob's health
    • Guidance for health professionals
      • Diagnosis
      • Treatment
      • Surgery
      • Medical oncology
      • Radiation oncology
      • Primary care
      • Telehealth
      • Clinical trials
      • Follow-up care
      • Supportive and Palliative care
      • Cancer care for cancer patients with COVID-19
      • COVID-19 vaccines and cancer
      • Recovery
    • Research articles
      • Review articles
      • Data articles
      • Recommendations articles
      • Shared experience articles
      • COVID-19 vaccines and cancer articles
    • Cancer care in the time of COVID-19: A conceptual framework
    • Optimal cancer care during the COVID-19 pandemic: the Principles
    • The impact of COVID-19 on cancer services
    • COVID-19 Recovery: Implications for cancer care
      • Expanded use of telehealth
      • Changes to prevention and early detection
      • Virtual multidisciplinary team meetings
      • Modifications to treatment schedules
      • Hypofractionated radiotherapy
      • Oncology hospital in the home
      • Responsive patient support
      • Innovative care and hospital infrastructure models
      • Shared follow-up and survivorship care
      • Supportive and palliative care
      • Cancer research and clinical trials
      • Collaboration in the oncology sector and data sharing
      • Acknowledgements
  • About us
    • Organisational structure
    • Accountability and reporting
      • Annual reports
    • Who we work with
      • Roles & functions
      • Advisory Council
      • Advisory groups
      • Consumer engagement
      • Government cancer control organisations
    • Information publication scheme
      • Information publication scheme plan
      • Freedom of information act
        • The FOI request process
      • FOI disclosure log
    • Reconciliation action plan
    • Employment opportunities
  • News and media
    • News
    • Subscribe to our eNewsletter
  • Contact us
Cancer Australia
Choose Language
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • Home
  • Cancer types
  • Impacted by Cancer
  • Awareness
  • Research
  • Resources
  • Clinicians hub
  • Key initiatives
  • Home
  • Cancer types
    • Bladder cancer
    • Bowel cancer
    • Brain cancer
    • Breast cancer
    • Breast cancer in men
    • Breast cancer in young women
    • Cervical cancer
    • Children’s cancer
    • Endometrial cancer
    • Fallopian cancer
    • Gestational trophoblastic disease
    • Gynaecological cancers
    • Head and neck cancer
    • Kidney cancer
    • Leukaemia
    • Liver cancer
    • Lung cancer
    • Lymphoma
    • Melanoma
    • Mesothelioma cancer
    • Myeloma
    • Neuroendocrine tumours
    • Oesophageal cancer
    • Ovarian cancer
    • Pancreatic cancer
    • Prostate cancer
    • Sarcoma
    • Stomach cancer
    • Testicular cancer
    • Thyroid cancer
    • Unknown primary cancer
    • Uterine sarcoma
    • Vaginal cancer
    • Vulvar cancer
  • Impacted by Cancer
    • What is cancer
    • Physical changes
    • Treatment
    • Keeping healthy
    • Emotions
    • Family and relationships
    • Living with cancer
  • Awareness
    • Your cancer risk
    • Screening
    • Interactive body map
  • Research
    • Cancer Research in Australia
    • Data and statistics
    • Australian Clinical Trials
    • Support for cancer clinical trials
    • Grants and funding
  • Resources
    • Cancer Australia Publications
    • Clinical Practice Guidelines
    • Position statements
    • Resources in other languages
    • Cancer Australia websites
    • Cancer risk online assessment tools
    • Other tools and resources
    • Podcasts
    • Cancer support organisations
    • Glossary
  • Clinicians hub
    • GP guides and resources
    • Guidelines by cancer type
    • Optimal cancer care pathways
    • Working with Aboriginal and Torres Strait Islander people
    • Multidisciplinary care
    • Psychosocial care
    • Follow-up care
    • Family cancer clinics
    • Cancer Learning
    • Consumer engagement
  • Key initiatives
    • For Aboriginal and Torres Strait Islander people
    • Australian Cancer Plan
    • Australian Brain Cancer Mission
    • Jeannie Ferris Award
    • Lung Cancer Screening
    • National Pancreatic Cancer Roadmap
    • Campaigns & events

Fallopian cancer

fallopian-mm cancer-types/fallopian-cancer/overview
    • Home
    • Types
    • Statistics
    • Risk factors
    • Symptoms
    • Diagnosis
    • Screening
    • Treatment
      • Effects on fertility
    • Living with
    • Finding support
    • Clinical trials
    • Health professionals
    • Home
    • Types
    • Statistics
    • Risk factors
    • Symptoms
    • Diagnosis
    • Screening
    • Treatment
      • Effects on fertility
    • Living with
    • Finding support
    • Clinical trials
    • Health professionals
  1. Home
  2. Treatment
  3. Effects on fertility
  • Effects on fertility
Loading...

Effects on fertility

  • Printer-friendly version
  • A|A

Some young women will develop a cancer involving their reproductive organs before they have completed their family.

The cancer may pose a significant threat to your subsequent chance of having a baby. This presents a further psychological burden when you are already coping with the recent distressing news that you have cancer.

In this time of anxiety and concern, it is essential that you receive concise and up-to-date information from a recognised fertility expert. You should be referred to a respected unit for this advice. The Reproductive Technology Accreditation Committee, under the Fertility Society of Australia, administers a national code of practice and a system for the accreditation of assisted reproductive technology clinics. For a list of accredited clinics in Australia and New Zealand, see the website of the Fertility Society of Australia.

The way that the cancer may affect your chance of conceiving is two-fold. Fertility problems may occur as a result of essential surgery, or as a result of chemotherapy or radiotherapy after the surgery.

Many women also experience body-image concerns after surgery, which may lead to having sexual intercourse less frequently. This is a major determinant of the chance of conceiving naturally; hence, for many reasons, many women will seek fertility assistance.

In most cases, fallopian tube cancer is treated by hysterectomy (removal of the uterus), and removal of both ovaries and fallopian tubes. This means that it is no longer possible to become pregnant.

There are some situations where the cancer is very early and is confined to just one fallopian tube, and there is no evidence of spread elsewhere in the body. In this case, it may be possible to keep the other ovary, tube and uterus, and the woman may be able to retain her fertility.

This is not a very common situation because fallopian tube cancer is usually more advanced when it is diagnosed, but the desire for fertility should always be discussed with your gynaecologic oncologist, so that if your cancer is discovered to be at a very early stage, a lesser but adequate treatment option can be considered.

Fertility-sparing options

If one ovary remains after surgery, chemotherapy and/or radiotherapy may affect the number of eggs left within the ovary and, in many cases, accelerate the normal age-related decline in egg numbers.

In some cases, this may lead to an early menopause, and hence the need to use another woman’s eggs (egg donation treatment) to become pregnant. Hormone replacement therapy can help with managing the symptoms of early menopause.

If an ovary is retained, you can talk to a fertility specialist about your options to limit the harm from chemotherapy.

These may include the following.

Ovarian suppression

An implant containing a drug called a GnRH analogue may be used to suppress the function of the ovaries for the duration of chemotherapy. There is some evidence that this may limit harm to the ovaries for women embarking on chemotherapy only.

Ovarian tissue freezing

One potential way to save some eggs for the future is to take a small slice of ovarian tissue. This is done by a minor operation before starting chemotherapy, or at the time of ovarian transposition surgery before starting radiotherapy.

The major downside to this technique is that it is still experimental – very few babies have been born from this treatment. Furthermore, it involves undergoing an operation, and then further surgery to reimplant the ovarian tissue. Evidence suggests that many women do not want the ovarian tissue replaced because of their fear of reintroducing tissue that may still contain cancer cells.

Freezing of eggs

If you are not in a stable relationship, you may opt to go through an IVF cycle. This takes up to one month before chemotherapy or radiotherapy starts. It involves daily injections to stimulate the ovaries and then, after a couple of weeks, a minor surgical procedure to have the eggs collected. These eggs are then rapidly frozen until they are needed. However, this technique should still be considered developmental, and success so far is limited.

Freezing embryos

If you are in a stable relationship and time permits, you may opt to go through an IVF cycle (described above), but in this case your eggs are fertilised with your partner’s sperm and the resulting embryos are frozen until they are used. The freezing of embryos is a more successful procedure than the freezing of eggs.

‘Wait and see’ policy

Many women find that these choices are too hard to make at this time of great anxiety. It may help to talk to the fertility counsellor who is always attached to an IVF unit.

  • Last Updated
  • Relevant Links
updated: 20 October 2020 - 3:32pm
Australian Cancer Research Foundation, Gynaecological cancer
National Cancer Institute (US), Ovarian epithelial, fallopian tube, and primary peritoneal cancer treatment (PDQ®), patient vers
Australian Cancer Trials
Rare Cancers Australia

Related information

What is cancer?
What is cancer?

Cancer is a disease of the cells, which are the body’s basic building blocks.

Treatment and side effects
Treatment and side effects

The treatment that your doctors recommend will depend on the type of cancer you have, how advanced it is, and other personal factors.

Living with cancer
Living with cancer

A diagnosis of cancer marks the beginning of a journey full of emotional, psychological, physical and practical challenges.

Life after cancer
Life after cancer

While looking forward to finishing their cancer treatment and getting on with life, for some people, the end of treatment can also be a confusing or worrying time.

A-Z List of Cancer Types

Information on more than 70 types of cancer

  • Bladder cancer
  • Bowel cancer
  • Brain cancer
  • Breast cancer
  • Breast cancer in men
  • Breast cancer in young women
  • Cervical cancer
  • Children's Cancer
  • Endometrial cancer
  • Fallopian cancer
  • Gestational trophoblastic disease
  • Gynaecological cancers
  • Head and neck cancer
  • Kidney cancer
  • Leukaemia
  • Liver cancer
  • Lung cancer
  • Lymphoma
  • Melanoma of the skin
  • Mesothelioma cancer
  • Myeloma
  • Neuroendocrine tumours
  • Oesophageal cancer
  • Ovarian cancer
  • Pancreatic cancer
  • Prostate cancer
  • Sarcoma
  • Stomach cancer
  • Testicular cancer
  • Thyroid cancer
  • Unknown primary
  • Uterine sarcoma
  • Vaginal cancer
  • Vulval cancer

About Cancer Australia

Cancer Australia was established by the Australian Government in 2006 to benefit all Australians affected by cancer, and their families and carers. Cancer Australia aims to reduce the impact of cancer, address disparities and improve outcomes for people affected by cancer by leading and coordinating national, evidence-based interventions across the continuum of care.

If you would like an interpreter to help you understand any information on this website, please call TIS National on 131 450 and ask them to call Cancer Australia on 02 9357 9400. Our business hours are 9am to 5pm, Monday to Friday.

Freecall 1800 624 973
+61 2 9357 9400

Locked Bag 3, Strawberry Hills
NSW 2012

Navigation

  • Cancer types
  • Impacted by Cancer
  • Awareness
  • Research
  • Resources
  • Clinicians hub
  • Key initiatives

Contact us

* Denotes mandatory fields
 

By submitting this form, you accept the Cancer Australia privacy policy.

  • Contact Us
  • Copyright
  • Disclaimer
  • Privacy policy
  • Sitemap
Copyright © 2023 - Cancer Australia